Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Discover 7 surprising ways asthma develops in adulthood – from workplace exposures to hormonal shifts. Frequently begins ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...

Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

Jazz Pharmaceuticals has drummed up a deal in double time, agreeing to buy Chimerix for $935 million just days after its CEO ...

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.

Drivers could face £1,000 fines or even lose their driving licence if they do not declare one of 110 medical conditions, the DVLA has warned. According to the government website, there is a long list ...

Now, researchers at UC San Diego have gotten it approved as the first effective drug therapy for sleep apnea. “Systol ...